We have 8 new companies:
- CM FINANCE INC (NEW YORK, NY)
- EGALET CORP (MALVERN, PA), PHARMACEUTICAL PREPARATIONS
- ELEVEN BIOTHERAPEUTICS, INC. (CAMBRIDGE, MA), PHARMACEUTICAL PREPARATIONS
- GENOCEA BIOSCIENCES, INC. (CAMBRIDGE, MA), BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
- LADDER CAPITAL CORP (NEW YORK, NY), REAL ESTATE
- NEW HOME CO INC. (ALISO VIEJO, CA), OPERATIVE BUILDERS
- REVANCE THERAPEUTICS, INC. (NEWARK, CA), PHARMACEUTICAL PREPARATIONS
- ULTRAGENYX PHARMACEUTICAL INC. (NOVATO, CA), PHARMACEUTICAL PREPARATIONS
We have 60 new people:
- AGUIAR-LUCANDER RENEE, a Director at EGALET CORP
- BAKHSHANDEHPOUR SAM, a Director at NEW HOME CO INC.
- BERMAN DAVID, a Director at NEW HOME CO INC.
- BILZIN JONATHAN, a Director at LADDER CAPITAL CORP
- BROWNE L DANIEL, CEO AND PRESIDENT at REVANCE THERAPEUTICS, INC.
- CEITLIN ANDREW, a Director at RESOURCE REAL ESTATE OPPORTUNITY REIT, INC.
- CELNIKER ABBIE, PRESIDENT AND CEO at ELEVEN BIOTHERAPEUTICS, INC.
- CHARY RAM, PRESIDENT & CEO at GLOBAL CASH ACCESS HOLDINGS, INC.
- CHRISTENSEN JAMIE, SVP & CHIEF SCIENTIFIC OFFICER at MIRATI THERAPEUTICS, INC.
- COOK EDWARD J., CHIEF COMPLIANCE OFFICER at CM FINANCE INC
- DANISH BIOTECH SPV I P/S, a major shareholder at EGALET CORP
- DECK BRIAN A, VP & CFO at JOHN BEAN TECHNOLOGIES CORP
- DURST DOUGLAS, a Director at LADDER CAPITAL CORP
- EASTMAN RONALD W, a Director at REVANCE THERAPEUTICS, INC.
- EVANGEL LORI M, EVP & CHIEF RISK OFFICER at GENWORTH FINANCIAL INC
- FINANCIERE DE SAINTE-MARINE, a major shareholder at HARRIS INTERACTIVE INC
- FOLSOM SUZANNE R, GC & SR VP - GOV AFFAIRS at UNITED STATES STEEL CORP
- FOX MARC, CHIEF FINANCIAL OFFICER at LADDER CAPITAL CORP
- FRANKS TOM, a Director at U.S. RARE EARTHS, INC
- FURFINE ERIC STEVEN, CHIEF SCIENCE OFFICER at ELEVEN BIOTHERAPEUTICS, INC.
- GALE JODY STORM, SVP, GENERAL COUNSEL,SECRETARY at FARO TECHNOLOGIES INC
- GLASHEEN JAMES WALTER, a Director at REVANCE THERAPEUTICS, INC.
- GRANT JEFFREY J, a person at BANKRATE, INC.
- GRAVITZ AARON, a Director at STREAMTRACK, INC.
- GUGGENHEIM GRETA, CHIEF INVESTMENT OFFICER at LADDER CAPITAL CORP
- HARNEY THOMAS, HEAD-MERCHANT BANKING & CAP MK at LADDER CAPITAL CORP
- HARRAR DEREK, a Director at BRIGHTCOVE INC
- HARRIS BRIAN, CHIEF EXECUTIVE OFFICER at LADDER CAPITAL CORP
- JANSEN CHRISTOPHER E, PRESIDENT AND SECRETARY at CM FINANCE INC
- JOHNSTON ROBERT V. II, EXECUTIVE VICE PRESIDENT at APACHE CORP
- KERREY ROBERT J., a Director at U.S. RARE EARTHS, INC
- KONDOS CAROL C., a Director at U.S. RARE EARTHS, INC
- KOZLOV ANDREY, a Director at EGALET CORP
- KUPPENHEIMER STEPHAN, a Director at CM FINANCE INC
- LADNIER MARK S, HEAD OF OPERATIONS & IT at PARK STERLING CORP
- LEE KEITH, a Director at CM FINANCE INC
- LINDHARDT KARSTEN, VP, RESEARCH & DEVELOPMENT at EGALET CORP
- LINDSTROM GREGORY P., a Director at NEW HOME CO INC.
- MAZZEI MICHAEL, PRESIDENT at LADDER CAPITAL CORP
- MCCORMACK PAMELA, CHIEF STRATEGY OFFICER & GC at LADDER CAPITAL CORP
- MUSIAL STAN, CHIEF FINANCIAL OFFICER at EGALET CORP
- PARK HOWARD, a Director at LADDER CAPITAL CORP
- PERELMAN ROBERT, HEAD OF ASSET MANAGEMENT at LADDER CAPITAL CORP
- PERSILY JULIE, a Director at CM FINANCE INC
- RADIE ROBERT S, PRESIDENT AND CHIEF EXECUTIVE at EGALET CORP
- RIGGS RORY B, a Director at INTRA-CELLULAR THERAPIES, INC.
- RUEGG CURTIS, EVP R&D AND TECH OPERATIONS at REVANCE THERAPEUTICS, INC.
- RUEGGER PHILIP T III, a Director at TRAVELERS COMPANIES, INC.
- RUST SCOTT ARTHUR, SENIOR VICE PRESIDENT at NATIONAL INSTRUMENTS CORP /DE/
- SCIRE ANTHONY, SEE REMARKS at CM FINANCE INC
- SEGERROS ANDREAS RUTGER, a Director at EGALET CORP
- SNOWDEN RAYMOND WARD, a person at GERMAN AMERICAN BANCORP, INC.
- SPELTZ CHRISTOPHER J, a person at BANKRATE, INC.
- STROBECK MARK, CHIEF BUSINESS OFFICER at EGALET CORP
- TUBRIDY KAREN L, CHIEF DEVELOPMENT OFFICER at ELEVEN BIOTHERAPEUTICS, INC.
- TUNNICLIFFE JONATHAN, a Director at REVANCE THERAPEUTICS, INC.
- WAGNER ROBERT T, a Director at CM FINANCE INC
- WAUGH JACOB, CHIEF SCIENTIFIC OFFICER at REVANCE THERAPEUTICS, INC.
- WITTE WILLIAM A., a Director at NEW HOME CO INC.
- WOOTEN RONALD J, a Director at REVANCE THERAPEUTICS, INC.
We have 40 new positions:
- AFEYAN NOUBAR, becomes a Director at ELEVEN BIOTHERAPEUTICS, INC.
- BELL MARC N, becomes a Director at SG BLOCKS, INC.
- BERRY DAVID A, becomes a Director at ELEVEN BIOTHERAPEUTICS, INC.
- BREGE LAURA, becomes a Director at ARATANA THERAPEUTICS, INC.
- BROCK JOHN, becomes a Director at ROYAL CARIBBEAN CRUISES LTD
- BYRNES ROBERT F, becomes a Director at REVANCE THERAPEUTICS, INC.
- COHEN RICHARD, becomes a person at SPHERIX INC
- DENUCCIO KEVIN A, becomes PRESIDENT AND CEO at VIOLIN MEMORY INC
- DORAN HOWARD JR, becomes PRESIDENT AND CEO at LIPOSCIENCE INC
- ELSER MARCO M, becomes a Director at PROTALEX INC
- FERRY JOHN J III, becomes VP & CHIEF ACCOUNTING OFFICER at WCI COMMUNITIES, INC.
- FISHMAN ALAN H, becomes a Director at LADDER CAPITAL CORP
- FORMELA JEAN FRANCOIS, becomes a Director at EGALET CORP
- FREIDHEIM STEPHEN C, becomes a major shareholder at CM FINANCE INC
- FREUND JOHN GORDON, becomes a major shareholder at DICERNA PHARMACEUTICALS INC
- GARDNER PHYLLIS, becomes a Director at REVANCE THERAPEUTICS, INC.
- GRAHAM THOMAS H, becomes a Director at OLD LINE BANCSHARES INC
- HEESCHEN PAUL C, becomes a Director at NEW HOME CO INC.
- HENDERSON JANE, becomes a Director at ELEVEN BIOTHERAPEUTICS, INC.
- KANEKO YASUNORI, becomes a major shareholder at DICERNA PHARMACEUTICALS INC
- KANIA EDWIN M JR, becomes a major shareholder at ELEVEN BIOTHERAPEUTICS, INC.
- KENDALL DONALD R JR, becomes CEO OF BLUE EARTH CAPITAL at BLUE EARTH, INC.
- KIMBELL DAVID C, becomes CHIEF MARKETING OFFICER at ULTA SALON, COSMETICS & FRAGRANCE, INC.
- LOSCALZO JOSEPH, becomes a Director at ISIS PHARMACEUTICALS INC
- LOWE CATHEY S, becomes a Director at NEW HOME CO INC.
- LYNCH DANIEL, becomes a Director at ELEVEN BIOTHERAPEUTICS, INC.
- MAUER MICHAEL, becomes CHIEF EXECUTIVE OFFICER at CM FINANCE INC
- NEFF DOUGLAS C, becomes a Director at NEW HOME CO INC.
- PERRY GREGORY D, becomes CHIEF FINANCIAL AND BUSINESS at ELEVEN BIOTHERAPEUTICS, INC.
- PETERSON JOEL CLINTON, becomes a Director at LADDER CAPITAL CORP
- POGORZELSKI STEVEN, becomes CHIEF REVENUE OFFICER at VOCUS, INC.
- RAINES MERILEE, becomes a Director at ARATANA THERAPEUTICS, INC.
- RYDER ROBERT P, becomes a Director at CM FINANCE INC
- SCELFO JOHN J, becomes a Director at GREEN EARTH TECHNOLOGIES, INC
- SILVERNAIL LAUREN P, becomes CFO, SERETARY & EVP CORP DEV. at REVANCE THERAPEUTICS, INC.
- TAYLOR SCOTT C, becomes a Director at PIPER JAFFRAY COMPANIES
- THOMPSON JOHN CRAIG, becomes CHIEF OPERATING OFFICER at TETRAPHASE PHARMACEUTICALS INC
- TUUK MARY E, becomes a person at UNIVERSAL FOREST PRODUCTS INC
- WATT NADINE I, becomes a Director at NEW HOME CO INC.
- WEAVER GREGORY L, becomes a Director at EGALET CORP
No comments:
Post a Comment